Efficacy, safety, and cost of new anticancer drugs : Pessimistic conclusion was not justified

Схожие документы

• Data presented do not justify pessimistic conclusions
  по: WRIGHT, C
  Опубликовано: (2001)
• Efficacy, safety, and cost of new anticancer drugs
  по: Garattini, Silvio, et al.
  Опубликовано: (2002)
• Tacrine and lecithin in Alzheimer's disease. Negative conclusions not justified.
  по: Wilcock, G. K.
  Опубликовано: (1994)
• Drug costs and drug safety.
  Опубликовано: (1967)
• Tuning the metabolism of the anticancer drug cisplatin with chemoprotective agents to improve its safety and efficacy
  по: Sooriyaarachchi, Melani, et al.
  Опубликовано: (2016)